Literature DB >> 19723738

Preference-weighted health status of PTSD among veterans: an outcome for cost-effectiveness analysis using clinical data.

Michael C Freed1, Derik E Yeager, Xian Liu, Kristie L Gore, Charles C Engel, Kathryn M Magruder.   

Abstract

OBJECTIVE: Posttraumatic stress disorder (PTSD) is a highly prevalent, chronic, disabling but treatable condition. Preference-based measures (for example, health utilities) are recommended for and useful in cost-effectiveness analyses and for policy decisions because they reflect a population's valuation of the desirability of disease states. However, no such measures exist for PTSD. This study aimed to estimate preference-weighted health status associated with PTSD and common co-occurring mental disorders in a sample of veterans by transforming health-related quality-of-life data into preference-weighted health status scores (PWHS scores), develop a usable regression model to predict PWHS scores from other data sets, and compare preference-weighted health status of PTSD with that of another chronic disorder, chronic obstructive pulmonary disease (COPD).
METHODS: A secondary analysis was performed on data from a random sample of 808 veterans (79% male; 12% met criteria for PTSD) in four primary care clinics. Veterans responded to the PTSD Checklist (PCL), Clinician-Administered PTSD Scale, Mini-International Neuropsychiatric Interview, and Medical Outcomes Survey Short Form-36.
RESULTS: PWHS scores were .029 lower among veterans with PTSD compared with veterans without PTSD, all else being equal. However, scores depended on PTSD severity, when the analysis controlled for other model variables. Specifically, PWHS scores dropped by .004 with a 1-unit increase in PCL scores among veterans without PTSD. Among veterans with PTSD, the reduction was .002. PTSD was associated with lower preference-weighted health status than COPD.
CONCLUSIONS: This is the first study to estimate preference-weighted health status of persons with PTSD. These PWHS scores can be helpful in cost-effectiveness studies of PTSD treatments.

Entities:  

Mesh:

Year:  2009        PMID: 19723738     DOI: 10.1176/ps.2009.60.9.1230

Source DB:  PubMed          Journal:  Psychiatr Serv        ISSN: 1075-2730            Impact factor:   3.084


  4 in total

1.  Cost-effectiveness of psychological treatments for post-traumatic stress disorder in adults.

Authors:  Ifigeneia Mavranezouli; Odette Megnin-Viggars; Nick Grey; Gita Bhutani; Jonathan Leach; Caitlin Daly; Sofia Dias; Nicky J Welton; Cornelius Katona; Sharif El-Leithy; Neil Greenberg; Sarah Stockton; Stephen Pilling
Journal:  PLoS One       Date:  2020-04-30       Impact factor: 3.240

2.  Predictors of health-related quality-of-life utilities among persons with posttraumatic stress disorder.

Authors:  Jason N Doctor; Lori A Zoellner; Norah C Feeny
Journal:  Psychiatr Serv       Date:  2011-03       Impact factor: 3.084

3.  Effects of treatment, choice, and preference on health-related quality-of-life outcomes in patients with posttraumatic stress disorder (PTSD).

Authors:  Quang A Le; Jason N Doctor; Lori A Zoellner; Norah C Feeny
Journal:  Qual Life Res       Date:  2018-03-14       Impact factor: 4.147

4.  Minimal clinically important differences for the EQ-5D and QWB-SA in Post-traumatic Stress Disorder (PTSD): results from a Doubly Randomized Preference Trial (DRPT).

Authors:  Quang A Le; Jason N Doctor; Lori A Zoellner; Norah C Feeny
Journal:  Health Qual Life Outcomes       Date:  2013-04-12       Impact factor: 3.186

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.